HealthDay News — For preextensively drug resistant tuberculosis (TB), a shortened bedaquiline, delamanid, linezolid, and clofazimine (BDLC) regimen is not noninferior to longer standard of care, ...

The silent pandemic of bacterial antimicrobial resistance is a leading cause of death worldwide, prolonging hospital stays and raising health-care costs. Poor incentives to develop novel ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

National Health Ratings reports high teen substance misuse rates vary by state, with New Mexico leading at 16%, highlighting ...

The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small ...

Antibiotic resistance is one of the biggest health threats we face today. It's often blamed on the overuse of antibiotics, ...

The comparative effectiveness, cost-effectiveness, and safety of different antibiotics have been highlighted as important issues, but currently little evidence is available to help resolve uncertainty ...

Scientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine ...

Most antibiotic classes currently in use were discovered and developed during those decades. Excluding the treatment of mycobacterial infections, 22 antibiotic classes are currently approved for ...

Targeting urease activity presents a promising strategy to reduce the H. pylori pathogenicity and enhance its susceptibility to antibiotics. Inhibiting urease enzyme activity would be an option to ...

A new study from researchers in Madison found antibiotic use for COVID-19 may do more harm than good.